Filing Details

Accession Number:
0001209191-17-018270
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-06 16:09:26
Reporting Period:
2017-03-02
Filing Date:
2017-03-06
Accepted Time:
2017-03-06 16:09:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
917520 Integra Lifesciences Holdings Corp IART Laboratory Analytical Instruments (3826) 510317849
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1461806 G. Raymond Murphy 311 Enterprise Drive
Plainsboro NJ 08536
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-02 5,238 $10.74 66,132 No 4 M Direct
Common Stock Disposition 2017-03-02 5,238 $43.01 60,894 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-03-02 5,238 $0.00 5,238 $10.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-05-20 No 4 M Direct
Footnotes
  1. On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4.
  2. The price shown above represents the weighted average price of the shares sold. The range of sale prices was $42.84 to $43.09.
  3. 25% of the stock options vested every quarter from the grant date of 5/20/2009.
  4. This employee's stock option was previously reported as covering 7,829 shares of common stock at an exercise price of $21.48 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.